Blue Owl Capital supports $4bn acquisition of PCI Pharma Services

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services

Blue Owl Capital backed the $4bn acquisition of PCI Pharma Services, a leading provider of pharmaceutical packaging and clinical trial solutions. The deal was led by Kohlberg & Company, with Blue Owl providing strategic financing to support the transaction. PCI...